J. Daniel Mccranie - 12 Aug 2025 Form 4 Insider Report for Enovix Corp (ENVX)

Reporting relationship: Director
Issuer ticker: ENVX
Reported as of: 12 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Aug 2025, 21:58:32 UTC
Prior SEC filing: 03 Feb 2025
Next SEC filing: 17 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Arthi Chakravarthy, Attorney-in-Fact for John Daniel McCranie

Key filing fact

J. Daniel Mccranie filed Form 4 for Enovix Corp (ENVX) on 26 Aug 2025.

Key facts

This page summarizes J. Daniel Mccranie's Form 4 filing for Enovix Corp (ENVX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Aug 2025, 21:58.

Change

Previous filing in this sequence was filed on 03 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001189710 Primary reporting owner

MCCRANIE J DANIEL

Relationship: Director
Address: C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT
Signature: /s/ Arthi Chakravarthy, Attorney-in-Fact for John Daniel McCranie
Signature date: 26 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENVX transaction

Common Stock

Award

Transaction value: $0
Shares: +25,700
Change %
Price: $0.000000
Shares after: 25,700
Date: 12 Aug 2025
Ownership: Direct
Footnotes: F1

ENVX transaction

Common Stock

Award

Transaction value: $0
Shares: +15,178
Change %: +59%
Price: $0.000000
Shares after: 40,878
Date: 12 Aug 2025
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 12 equal quarterly installments measured from August 12, 2025, the vesting commencement date, subject to the Reporting Person's continuous service through each applicable vesting date.

Footnote F2

Reflects shares issuable on the settlement of RSUs granted to the Reporting Person. 25% of the RSUs will vest on each of November 12, 2025, February 12, 2026, May 12, 2026 and the earlier of (i) June 12, 2026; or (ii) the date of the Issuer's 2026 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.

Footnote F3

Includes 40,878 shares issuable upon the settlement of RSUs granted to the Reporting Person.